Ironwood Pharmaceuticals, Inc. - Class A (IRWD)

Health Care·equity

$3.82

-1.29% today

Extended hours $3.86

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

61/ 100

Score level

Above average

6 of 6 checks had data

Score for how it compares with the broader market is near the top of its range.

IRWD scores higher than 86% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Ironwood Pharmaceuticals, Inc. - Class A (IRWD) scores 61 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.85× 30-day average
52-week range: 1.41 – 5.78
Market cap: $720.45M
Earnings date: 29 Oct 2026

Volume: 1,721,538
Avg. volume (30d): 2,025,585

Open: 3.88
Previous close: 3.87
Day's range (regular session): 3.81 – 3.95

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.23
P/E (TTM): 5.42
EPS (TTM): 0.76

Score breakdown · six named factors

Price trend

Strength vs the market

100

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for IRWD

2 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for IRWD. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about IRWD right now

Ironwood Pharmaceuticals, Inc. - Class A (IRWD) currently scores 61/100 on the Market Census six-factor composite, at the Above average score level. IRWD is -1.29% on the day and +5.77% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for IRWD leans good, with some weak spots. IRWD's strongest factor is strength vs the market at 100/100 — a very strong read on how IRWD has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 49/100 — middling company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See IRWD in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score